Emerging targets for anticancer vaccination: PD-1

Among the mechanisms by which tumor cells escape the immune surveillance, one is the interaction between programmed cell death protein 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1). Inhibition of the PD-1/PD-L1 pathway with monoclonal antibodies as immune checkpoint inhibitors targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobias, J., Steinberger, P., Drinić, M., Wiedermann, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517287/
https://www.ncbi.nlm.nih.gov/pubmed/34649221
http://dx.doi.org/10.1016/j.esmoop.2021.100278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517287/
https://www.ncbi.nlm.nih.gov/pubmed/34649221
http://dx.doi.org/10.1016/j.esmoop.2021.100278

Ejemplares similares